SENNA-S

Product NDC: 17714-124
Requested package NDC: 17714-124-10
11-digit product format: 177140124
Labeler code: 17714
Product ID: 17714-124_5cc973b8-e563-2f6c-e053-2a91aa0a9ab8
Type: HUMAN OTC DRUG
Nonproprietary name: Senna and Docusate Sodium Tablets, 8.6 mg and 50 mg
Dosage form: TABLET
Route: ORAL
Labeler: Advance Pharmaceutical Inc.
Application: part334
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2017-02-01
Marketing end: 0000-00-00
Substance: SENNOSIDES; DOCUSATE SODIUM
Active strength: 9 mg/1; mg/1
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	17714-124	17714-124-10	I	Inactivated by FDA		2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 15 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	`1332a3947898…`	`d4bfe170f9cd…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
17714-124-10	2023-01-30	C162847	48780-1	f386c64a-42b7-0266-e053-dadaa90a7c1a	Senna-S - Senna and Docusate Sodium Tablets, 8.6 mg & 50 mg

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
17714-124-10	SENNA-S	1000 in 1 BOTTLE	TABLET	1000		2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
17714-124	SENNA-S (SENNA AND DOCUSATE SODIUM TABLETS, 8.6 MG AND 50 MG) TABLET [ADVANCE PHARMACEUTICAL INC.]	2	Legacy NDC, 1 package rows	20171031_eccac127-5175-4a2e-828d-c9dd87713bb8.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
3FYP5M0IJX	SENNOSIDES		SENNOSIDES
F05Q2T2JA0	DOCUSATE SODIUM	577-11-7	DOCUSATE SODIUM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
998740	sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet	PSN	eccac127-5175-4a2e-828d-c9dd87713bb8	2
998740	docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SCD	eccac127-5175-4a2e-828d-c9dd87713bb8	2
998740	DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SY	eccac127-5175-4a2e-828d-c9dd87713bb8	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
17714-124-10	17714012410	1000 TABLET in 1 BOTTLE (17714-124-10)	1000 tablet	2017-02-01	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Senna-S - Senna and Docusate Sodium Tablets, 8.6 mg & 50 mg	Advance Pharmaceutical Inc. \| Time Cap Laboratories, Inc.	2017-10-30	HUMAN OTC DRUG LABEL	2